STOCK TITAN

[SCHEDULE 13G] Cidara Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Commodore Capital LP
Signature:Michael Kramarz
Name/Title:Managing Partner
Date:07/02/2025
Commodore Capital Master LP
Signature:Michael Kramarz
Name/Title:Authorized Signatory
Date:07/02/2025
Robert Egen Atkinson
Signature:Robert Egen Atkinson
Name/Title:Authorized Signatory
Date:07/02/2025
Michael Kramarz
Signature:Michael Kramarz
Name/Title:Authorized Signatory
Date:07/02/2025
Exhibit Information

Exhibit 1: Joint Filing Agreement

Cidara Theraptcs

NASDAQ:CDTX

CDTX Rankings

CDTX Latest News

CDTX Latest SEC Filings

CDTX Stock Data

1.66B
25.12M
0.89%
106.96%
9.41%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SAN DIEGO